![]() ![]() The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector. Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa.North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment. The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region.Based on animal type, the market is segmented into companion and production animals.Ĭompanion animals tend to hold a larger share in the market as pet owners are concerned for their pet’s health and well-being. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms. ![]() The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products.Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. New York, J(GLOBE NEWSWIRE) - announces the release of the report "Global Animal Pharmaceuticals Market By Product Type, By Product, By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025". Global Animal Pharmaceuticals Market By Product Type (Vaccine, Veterinary, Others), By Product (Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others), Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others), Anti-Inflammatories (NSAIDs, Corticosteroids, Others), Bronchodilators (Theophylline, Albuterol, Others)), By Animal Type (Companion Animals, Production Animals), By Registration (Generic, Patented), By Region, Forecast & Opportunities, 2025 This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. ![]()
0 Comments
Leave a Reply. |